IM Therapeutics Spins Out of University of Colorado to Focus on Type 1 Diabetes Post author:Sam Post published:November 9, 2017 Post category:BioPharma ImmunoMolecular Therapeputics officially launched yesterday. Source: BioSpace You Might Also Like Why This Pharma May be the Best CAR-T Bet, Not Gilead October 19, 2017 Efficacy Of Royal Philips Electronics N.V.' Stellarex .035" Low-Dose Drug-Coated Balloon Demonstrated In Clinical Trial At Two Years September 14, 2017 CRO Giant PAREXEL Explores $4 Billion Sale, Stock Jumps May 8, 2017
Efficacy Of Royal Philips Electronics N.V.' Stellarex .035" Low-Dose Drug-Coated Balloon Demonstrated In Clinical Trial At Two Years September 14, 2017
